Raabta Pharma Private Limited, a active private limited company, was established on 23 August 2018 in Hyderabad, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24236TG2018PTC126275. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Gudelli Supriya Patak (Director), Pusati Bhaskar Reddy (Director). Past directors included Surendra Babu Labbi. It holds ₹4.03 M open charges and no settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at Flat No. 505, Vaishnavi Exotica Street No. 3, Kakatiya Nagar, Habsiguda, Hyderabad, Telangana, 500007.
U24236TG2018PTC126275
126275
23 August 2018
₹2.00 M
₹0.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Raabta Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gudelli Supriya Patak | Director | 23 Aug 2018 | Current |
| Pusati Bhaskar Reddy | Director | 23 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raabta Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 4810.1% increase. The company also saw a slight decrease in profitability, with a 9.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 206.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Raabta Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,025,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2021 | City Union Bank Limited | ₹4.03 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Raabta Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Raabta Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raabta Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Raabta Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was completed.
Raabta Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.
A charge with City Union Bank Limited amounted to Rs. 4.03 M with Charge ID 100485138 was registered on 10 Aug 2021. was recorded as a recent event.
Progress on Gudelli Supriya Patak was appointed as a Director was appointed as a Director on 23 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
Progress on Pusati Bhaskar Reddy was appointed as a Director was appointed as a Director on 23 Aug 2018 & has been associated with this company since 7 years 3 months . was documented.
Raabta Pharma Private Limited was registered on 23 Aug 2018 with Roc Hyderabad & aged 7 years 3 months as per MCA records. was recorded as a recent event.
The CIN of Raabta Pharma Private Limited is U24236TG2018PTC126275.
Raabta Pharma Private Limited is headquartered at Flat No. 505, Vaishnavi Exotica Street No. 3, Kakatiya Nagar, Habsiguda, Hyderabad, Telangana, 500007.
Raabta Pharma Private Limited was incorporated on 23 August 2018.
The current directors of Raabta Pharma Private Limited are
The primary industry of Raabta Pharma Private Limited is Manufacturing.
Raabta Pharma Private Limited is unlisted.
The authorized capital of Raabta Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX